Team leader defining and developing Freenome’s diagnostic solution digital interface so that it is an efficient, intuitive and amazing experience for patients, providers and payers.

(Acquired May 2022) - Deep Lens raised $17M (Northpond Ventures, Sierra Ventures, Rev1 Ventures and Tamarind Hill Fund) and was acquired in an all cash deal with substantial returns to all investors. Deep Lens technology allows democratization of access to clinical trials so that all patients, regardless of where they receive their care, can gain access to the best treatments science offers. We speed up the process of getting patients these life changing treatments and decrease the time for novel oncology drugs to become commercially available. The right patients, getting the right treatments at the right time.

At Fuse, Cardinal Health's Innovation Center, we built game changing technologies in healthcare that remove friction in the system allowing care providers, payers and patients to adopt revolutionary treatments to maximize the quality of our lives.

I had general management responsibility including business strategy, branding, marketing, and product development functions for a best-in class patent search system relied on by global pharmaceutical industry, government patent offices, and technology organizations. We migrated to Hadoop and open-source technology and moved to an Agile development philosophy during my time leading the team.

Advised pharma/biotech/healthcare and device companies on broad and diverse business strategy, market opportunities, and value optimization

Advise lifescience-healthcare / technology start-ups on funding, business planning, strategy and monetization opportunities